09 Sep 2015
(MENAFN) Hikma Pharmaceuticals plc, the fast growing multinational pharmaceutical group, said it will acquire 98.09 percent of the share capital of EIMC United Pharmaceuticals (EUP).
Egypt’s EUP is a pharmaceutical manufacturing company specializing in oncology products. The acquisition of EUP strengthens Hikma’s position in the large and fast growing Egyptian market.
Hikma’s operations are conducted through three businesses: “Branded”, “Injectables” and “Generics” based mainly in MENA region. In 2014, it achieved revenues of USD1.48 billion and profit of USD299 million.
08 Apr 2026
BBK awards over BD 1 Million to 273 winners in the February Al Hayrat Grand Prizes draw
01 Mar 2026
BBK activates partial remote working system for its workforce to ensure employee and customer safety and service continuity
24 Feb 2026
BBK discloses its financial results for the year ended 31st December 2025
05 Feb 2026
BBK announces December Al Hayrat Grand Prize winners and another wave of Grand prizes for February
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more